Baxter International's financial metrics for Q4 2024 show a slight increase in total revenue, while costs remained relatively stable with a minor decrease in cost of sales and a slight increase in R&D and selling, general, and administrative expenses1:
- Revenue Growth: The total revenue for Baxter International in Q4 2024 was $2.75 billion, representing a year-over-year growth of 0.01%.
- Cost of Sales: The cost of sales decreased by 1.07%, from $1.79 billion to $1.63 billion.
- R&D Expenses: Research and development (R&D) expenses increased by 0.66%, from $127 million to $211 million.
- Selling, General, and Administrative Expenses: These expenses also saw a slight increase of 0.11%, amounting to $761 million.
- Profitability Implications: The slight increase in revenue and R&D expenses, while costs of sales decreased, suggests a more efficient cost structure. However, the overall increase in expenses and the slight revenue growth indicate that Baxter is focusing on innovation and maintaining its market position.
BAX Selling, General, and Administrative Expenses, Cost of Goods Sold...
4/14/2025 07:28am
